Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Pharmacoepidemiology and Drug Safety
|
January 8, 2026
Assessment of a Modified High-Dimensional Propensity Score Approach for UK Electronic Health Record Data: Evaluating Upper Gastrointestinal Safety of NSAIDs and COX-2 Inhibitors
John Tazare, Daniel C Gibbons, Liam Smeeth, et al.
Rheumatology (Oxford, England)
|
January 17, 2019
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
Samuel Hawley, M Sanni Ali, René Cordtz, et al.
Clinical Epidemiology
|
October 24, 2018
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
Sara Khalid, Sara Calderon-Larrañaga, Samuel Hawley, et al.
Pharmacoepidemiology and Drug Safety
|
January 31, 2014
Propensity score balance measures in pharmacoepidemiology: a simulation study
M Sanni Ali, Rolf H H Groenwold, Wiebe R Pestman, et al.
Journal of Clinical Epidemiology
|
December 1, 2014
Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review
M Sanni Ali, Rolf H H Groenwold, Svetlana V Belitser, et al.
Clinical Pharmacology and Therapeutics
|
May 8, 2018
Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)
Hongbo Yuan, M Sanni Ali, Emily S Brouwer, et al.
Frontiers in Pharmacology
|
October 18, 2019
Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances
M Sanni Ali, Daniel Prieto-Alhambra, Luciane Cruz Lopes, et al.
BMJ (Clinical Research Ed.)
|
April 2, 2024
Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations
Jeremy P Brown, Jacob N Hunnicutt, M Sanni Ali, et al.
Epidemiology (Cambridge, Mass.)
|
July 31, 2014
Quantitative falsification of instrumental variables assumption using balance measures
M Sanni Ali, Md Jamal Uddin, R H H Groenwold, et al.
Pharmacoepidemiology and Drug Safety
|
October 8, 2024
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
Jeremy P Brown, Jacob N Hunnicutt, M Sanni Ali, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Pharmacoepidemiology and Drug Safety
|
January 8, 2026
Assessment of a Modified High-Dimensional Propensity Score Approach for UK Electronic Health Record Data: Evaluating Upper Gastrointestinal Safety of NSAIDs and COX-2 Inhibitors
John Tazare, Daniel C Gibbons, Liam Smeeth, et al.
Rheumatology (Oxford, England)
|
January 17, 2019
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
Samuel Hawley, M Sanni Ali, René Cordtz, et al.
Clinical Epidemiology
|
October 24, 2018
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
Sara Khalid, Sara Calderon-Larrañaga, Samuel Hawley, et al.
Pharmacoepidemiology and Drug Safety
|
January 31, 2014
Propensity score balance measures in pharmacoepidemiology: a simulation study
M Sanni Ali, Rolf H H Groenwold, Wiebe R Pestman, et al.
Journal of Clinical Epidemiology
|
December 1, 2014
Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review
M Sanni Ali, Rolf H H Groenwold, Svetlana V Belitser, et al.
Clinical Pharmacology and Therapeutics
|
May 8, 2018
Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG)
Hongbo Yuan, M Sanni Ali, Emily S Brouwer, et al.
Frontiers in Pharmacology
|
October 18, 2019
Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances
M Sanni Ali, Daniel Prieto-Alhambra, Luciane Cruz Lopes, et al.
BMJ (Clinical Research Ed.)
|
April 2, 2024
Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations
Jeremy P Brown, Jacob N Hunnicutt, M Sanni Ali, et al.
Epidemiology (Cambridge, Mass.)
|
July 31, 2014
Quantitative falsification of instrumental variables assumption using balance measures
M Sanni Ali, Md Jamal Uddin, R H H Groenwold, et al.
Pharmacoepidemiology and Drug Safety
|
October 8, 2024
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
Jeremy P Brown, Jacob N Hunnicutt, M Sanni Ali, et al.
Page
of 5